China shares climb ahead of Trump-Xi summit; tech stocks inch up

By Reuters News

HONG KONG, Sept 21 (Reuters) - China and Hong Kong stocks rose on Monday, led by technology and property shares, as investors hoped that the US and China would extend a trade truce, with presidents Donald Trump and Xi Jinping due to meet this week.

** At the midday break, the Shanghai Composite index .SSEC was up 0.6% at 3,933.37 points. China's blue-chip CSI300 index .CSI300 was up 0.4%.

** The start-up board ChiNext Composite index .CNT was higher by 0.9% and Shanghai's tech-focused STAR50 index .STAR50 was up 0.4%​. The CSI AI Index .CSI930713 added 1.1%.

** Tech shares gained after US Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng concluded talks in New York on Sunday, with the US side proposing a new AI safety notification mechanism ahead of the Trump-Xi summit on September 24.

** Market expectations for the meeting are tempered, but the main focus is whether the leaders will signal an extension to a trade truce struck last year.

** "Overall, we think both sides will seek to maintain relative stability in US-China relations, although a broad bilateral agreement appears unlikely," analysts at Goldman Sachs said in a note.

** Among other gainers, the real estate sector .CSI000952 surged 4.6% and the defence sector .CSI399959 added 1.7%.

** Healthcare .CSI300HC rose more than 3% after a Reuters report that the US is working on rules for pharmaceutical companies investing in China that would likely preserve their ability to strike most licensing deals for Chinese drugs.

** In Hong Kong, the benchmark Hang Seng Index .HSI was up 0.6% at 24,891.58, and the Hang Seng Tech Index .HSTECH was little changed.

** Share markets edged higher in Asia on Monday as chipmakers climbed, while oil eased on reports that more oil was finding its way out of the Middle East than previously thought, despite the ongoing conflict in the Gulf.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.